asparaginase erwinia chrysanthemi (recombinant)-rywn

{
  "id": "MLC-T-ONC-011255",
  "term": "asparaginase erwinia chrysanthemi (recombinant)-rywn",
  "field": "Oncology and biomedicine",
  "definition": "A recombinant form of asparaginase (Erwinia asparaginase; crisantaspase) derived from the bacterium Erwinia chrysanthemi, genetically engineered to be produced in Pseudomonas fluorescens, with potential antineoplastic activity. Upon administration of recombinant asparaginase Erwinia chrysanthemi-rywn, the recombinant asparaginase hydrolyzes L-asparagine to L-aspartic acid and ammonia. This depletes cancer cells of asparagine, which blocks protein synthesis and tumor cell proliferation. Asparagine is critical to protein synthesis in cancer cells, which cannot synthesize this amino acid due to the absence of the enzyme asparagine synthase. It can be used as an alternative in patients who are hypersensitive to Escherichia (E.) coli-derived asparaginase products.",
  "synonyms": [
    "recombinant asparaginase Erwinia chrysanthemi-rywn",
    "RC-P JZP-458",
    "crisantaspase biobetter JZP-458",
    "recombinant crisantaspase JZP-458",
    "recombinant Asparaginase erwinia chrysanthemi JZP-458"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/asparaginase-erwinia-chrysanthemi-recombinant-rywn/"
}